RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 72 filers reported holding RECRO PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $341,019 | +667.0% | 315,758 | +148.9% | 0.00% | – |
| Q4 2023 | $44,464 | -25.3% | 126,858 | 0.0% | 0.00% | – |
| Q3 2023 | $59,496 | -54.6% | 126,858 | +6.5% | 0.00% | – |
| Q2 2023 | $131,074 | -7.6% | 119,158 | 0.0% | 0.00% | – |
| Q1 2023 | $141,798 | -60.1% | 119,158 | -50.0% | 0.00% | – |
| Q4 2022 | $355,090 | +88.9% | 238,316 | +106.6% | 0.00% | – |
| Q3 2022 | $188,000 | +104.3% | 115,376 | 0.0% | 0.00% | – |
| Q2 2022 | $92,000 | -55.8% | 115,376 | 0.0% | 0.00% | – |
| Q1 2022 | $208,000 | +20.9% | 115,376 | +15.0% | 0.00% | – |
| Q4 2021 | $172,000 | -16.9% | 100,355 | 0.0% | 0.00% | – |
| Q3 2021 | $207,000 | -10.8% | 100,355 | 0.0% | 0.00% | – |
| Q2 2021 | $232,000 | -77.3% | 100,355 | -72.7% | 0.00% | – |
| Q1 2021 | $1,024,000 | -0.9% | 367,159 | +1.3% | 0.00% | – |
| Q4 2020 | $1,033,000 | +20.4% | 362,439 | -11.3% | 0.00% | – |
| Q3 2020 | $858,000 | -53.8% | 408,639 | +0.1% | 0.00% | – |
| Q2 2020 | $1,858,000 | -44.9% | 408,273 | -1.1% | 0.00% | – |
| Q1 2020 | $3,374,000 | -54.7% | 412,963 | +1.6% | 0.00% | -100.0% |
| Q4 2019 | $7,453,000 | +70.3% | 406,581 | +3.0% | 0.00% | – |
| Q3 2019 | $4,376,000 | +42.9% | 394,904 | +31.2% | 0.00% | – |
| Q2 2019 | $3,062,000 | +112.8% | 301,049 | +22.6% | 0.00% | – |
| Q1 2019 | $1,439,000 | -13.7% | 245,589 | +4.6% | 0.00% | – |
| Q4 2018 | $1,667,000 | -2.8% | 234,752 | -2.7% | 0.00% | – |
| Q3 2018 | $1,715,000 | +46.1% | 241,387 | +3.1% | 0.00% | – |
| Q2 2018 | $1,174,000 | -49.8% | 234,095 | +10.3% | 0.00% | – |
| Q1 2018 | $2,339,000 | +23.5% | 212,222 | +3.7% | 0.00% | – |
| Q4 2017 | $1,894,000 | +37.6% | 204,660 | +33.5% | 0.00% | – |
| Q3 2017 | $1,376,000 | +31.4% | 153,250 | +2.9% | 0.00% | – |
| Q2 2017 | $1,047,000 | – | 148,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |